Cargando…

European Pediatric Societies and severe acute respiratory syndrome coronavirus-2 vaccination in children under age 12 years: a different path in England?

Detalles Bibliográficos
Autor principal:	Brown, Katherine L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522487/ https://www.ncbi.nlm.nih.gov/pubmed/34673089 http://dx.doi.org/10.1016/j.jpeds.2021.10.007

Ejemplares similares

Viewpoint of the European Pediatric Societies over Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination in Children Younger Than Age 12 Years Amid Return to School and the Surging Virus Variants
por: Pettoello-Mantovani, Massimo, et al.
Publicado: (2021)

Importance of Coronavirus Disease 2019 Vaccination in Children: Viewpoint and Recommendations of the Union of European National Societies of Pediatrics
por: Pettoello-Mantovani, Massimo, et al.
Publicado: (2022)

Immune response to the severe acute respiratory syndrome coronavirus 2 vaccines: Is it sustained in the diabetes population?
por: Rouka, Erasmia, et al.
Publicado: (2022)

Comment regarding pediatric severe acute respiratory syndrome coronavirus 2: clinical presentation, infectivity, and immune responses
por: Ferranti, Juliana Ferreira, et al.
Publicado: (2021)

Progress in immunization of children against coronavirus disease 2019: The role of pediatric societies
por: Gallegos, Miguel, et al.
Publicado: (2022)

Cutaneous vasculitis after severe acute respiratory syndrome coronavirus 2 vaccine
por: Colia, Ripalta, et al.
Publicado: (2021)

Severe acute respiratory syndrome coronavirus 2 vaccination and cancer therapy: A successful but mindful mix
por: Di Giacomo, Anna M., et al.
Publicado: (2021)

Do Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines Change Creutzfeldt-Jakob Disease Prognosis?
por: Doğru, Yüce, et al.
Publicado: (2022)

Italian pediatric respiratory society recommendations on pediatric pulmonary function testing during COVID-19 pandemic
por: Bignamini, Elisabetta, et al.
Publicado: (2020)

Risk of heparinoid use in cosmetics and moisturizers in individuals vaccinated against severe acute respiratory syndrome coronavirus 2
por: Yamamoto, Kenji
Publicado: (2021)

Acute disseminated encephalomyelitis after severe acute respiratory syndrome coronavirus 2 vaccination: a case report
por: Cao, Liming, et al.
Publicado: (2021)

Asymptomatic Severe Acute Respiratory Syndrome–associated Coronavirus Infection
por: Lee, Harold K.K., et al.
Publicado: (2003)

The neuroinvasive potential of severe acute respiratory syndrome coronavirus 2
por: Sun, Tong, et al.
Publicado: (2020)

Update of European Society of Clinical Microbiology and Infectious Diseases coronavirus disease 2019 guidelines: diagnostic testing for severe acute respiratory syndrome coronavirus 2
por: Fragkou, Paraskevi C., et al.
Publicado: (2023)

Severe acute respiratory syndrome coronavirus 2 in pregnancy: symptomatic pregnant women are only the tip of the iceberg
por: Khalil, Asma, et al.
Publicado: (2020)

Gross hematuria following vaccination for severe acute respiratory syndrome coronavirus 2 in 2 patients with IgA nephropathy
por: Negrea, Lavinia, et al.
Publicado: (2021)

Systemic capillary leak syndrome complicated by laryngeal edema after severe acute respiratory syndrome coronavirus 2 vaccination
por: Tanabe, Maki, et al.
Publicado: (2021)

Comment on “Comparison of severe acute respiratory syndrome coronavirus 2 (COVID-19) vaccine side effects by age groups”
por: Wang, Qiongjiao, et al.
Publicado: (2022)

Vaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection)
por: Sherman, Amy C., et al.
Publicado: (2022)

The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort
por: Sendi, Parham, et al.
Publicado: (2022)

Answers to comments on “Comparison of severe acute respiratory syndrome coronavirus 2 (COVID-19) vaccine side effects by age groups”
por: Tosun, Fadime, et al.
Publicado: (2023)

Management of severe asthma: summary of the European Respiratory Society/American Thoracic Society task force report
por: Khurana, Sandhya, et al.
Publicado: (2020)

European Pediatric Societies Call for an Implementation of Regular Vaccination Programs to Contrast the Immunity Debt Associated to Coronavirus Disease-2019 Pandemic in Children
por: Cohen, Robert, et al.
Publicado: (2022)

Effect of Pediatric Influenza Vaccination on Antibiotic Resistance, England and Wales
por: Chae, Chungman, et al.
Publicado: (2020)

Comment on evidence for and against vertical transmission of severe acute respiratory syndrome coronavirus 2 (coronavirus disease 2019)
por: Brion, Luc Pierre, et al.
Publicado: (2020)

Diagnostic performance of antigen testing for severe acute respiratory syndrome coronavirus 2
por: Marchán-López, Álvaro, et al.
Publicado: (2021)

Severe acute respiratory syndrome coronavirus 2 pandemic and surgical diseases: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Severe forms of COVID-19 among patients with chronic respiratory diseases: be attentive to the severity of the underlying respiratory impairment
por: Valentin, S., et al.
Publicado: (2022)

The Path to New Pediatric Vaccines against Pertussis
por: Locht, Camille
Publicado: (2021)

Authors’ comments on “branch retinal vein occlusion post severe acute respiratory syndrome coronavirus 2 vaccination”
por: Nagasato, Daisuke, et al.
Publicado: (2022)

Drug Shortages in Pediatrics in Europe: The Position of the European Pediatric Societies
por: Huss, Gottfried, et al.
Publicado: (2023)

Testing the Asymptomatic Pre-Surgical Population for Severe Acute Respiratory Syndrome Coronavirus 2
por: Bobenchik, April M., et al.
Publicado: (2021)

Stability of severe acute respiratory syndrome coronavirus 2 RNA in placenta and fetal cells
por: Pomar, Léo, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2–related Acute-on-chronic Liver Failure
por: Kumar, Pramod, et al.
Publicado: (2021)

Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times?
por: Ferrara, Francesco, et al.
Publicado: (2020)

Rapid Emergence of the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Korea
por: Park, Ae Kyung, et al.
Publicado: (2023)

Pediatric Coronavirus Disease 2019: Why Is It Less Severe and Frequent in Children than Adults?
por: Jadali, Zohreh
Publicado: (2021)

Early Impact of Severe Acute Respiratory Syndrome Coronavirus 2 on Pediatric Clinical Research: A Pan-European and Canadian Snapshot in Time
por: Mantha, Olivier L., et al.
Publicado: (2021)

European Respiratory Society: 15th Annual Congress of the European Respiratory Society; 17–21 September 2005; Copenhagen, Denmark
por: Kitler, Mary Ellen
Publicado: (2012)

Severe acute respiratory syndrome coronavirus 2: virus mutations in specific European populations
por: Coppée, F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9ig1t68md00j4g2b30htodqn3g